Published by Josh White on 23rd August 2023
(Sharecast News) - Cancer treatment developer BiVictriX Therapeutics has secured a significant patent from the United States Patent and Trademark Office (USPTO), it announced on Wednesday, for its flagship therapeutic asset, BVX001.
URL: http://www.digitallook.com/dl/news/story/33722041/...